Applying lessons from the pandemic for non-invasive sample collection for infectious diseases: From saliva collection for COVID testing to urine self-sampling for HPV testing
Tuesday, July 26, 2022
Sign up to receive link to the workshop recording
Overview:
During the COVID-19 pandemic, there was an increased need for non-invasive, self-collection of samples for diagnostic testing for SARS-CoV-2 as well as at-home collection solutions for other infectious diseases, including detection of Human Papilloma Virus (HPV) that can cause cervical cancers and other STI infections.
In this session, we’ll discuss the impact of the pandemic on using non-traditional sample types for diagnostic testing, including data on the benefits of utilizing saliva as a sample type for SARS-CoV-2 testing during a pandemic. We will also explore advances in utilizing first-void urine as a non-invasive, self-sampling method for detection of HPV.
Outcomes:
After attending this session, participants will be able to:
1. Understand the contributing factors of the COVID-19 pandemic that highlighted the critical need for non-invasive (at-home) self-collection of samples for diagnostic testing.
2. Learn how utilizing saliva collection (in both adults and children) for SARS-Cov-2 testing enabled a clinical lab to support their community by providing non-invasive, self-collection of saliva samples for testing and variant monitoring.
3. Explore the advances in clinical data supporting first-void urine as a non-invasive, (at-home) self-collection sampling method for detection of HPV.
By submitting this request, I consent to receive follow-up emails from DNA Genotek Inc., its parent company, OraSure Technologies, Inc. and their affiliates, about products and services, news, and promotions. Please refer to our Privacy Policy or Contact Us for more details. I understand that I can withdraw consent at any time.
Register Here
Applying lessons from the pandemic for non-invasive sample collection for infectious diseases:
From saliva collection for COVID testing to urine self-sampling for HPV testing
Tuesday, July 26, 2022
Sign up to receive link to the workshop recording
Overview:
During the COVID-19 pandemic, there was an increased need for non-invasive, self-collection of samples for diagnostic testing for SARS-CoV-2 as well as at-home collection solutions for other infectious diseases, including detection of Human Papilloma Virus (HPV) that can cause cervical cancers and other STI infections.
In this session, we’ll discuss the impact of the pandemic on using non-traditional sample types for diagnostic testing, including data on the benefits of utilizing saliva as a sample type for SARS-CoV-2 testing during a pandemic. We will also explore advances in utilizing first-void urine as a non-invasive, self-sampling method for detection of HPV.
Outcomes:
After attending this session, participants will be able to:
1. Understand the contributing factors of the COVID-19 pandemic that highlighted the critical need for non-invasive (at-home) self-collection of samples for diagnostic testing.
2. Learn how utilizing saliva collection (in both adults and children) for SARS-Cov-2 testing enabled a clinical lab to support their community by providing non-invasive, self-collection of saliva samples for testing and variant monitoring.
3. Explore the advances in clinical data supporting first-void urine as a non-invasive, (at-home) self-collection sampling method for detection of HPV.
Moderator
Mara G. Aspinall, MBA
Managing Director of BlueStone Venture Partners investing in diagnostics, devices and HIT companies.She leads the Health Catalysts Group, publishingthe popular Health Catalysts Diagnostics Year in Review. Aspinall is an advisor to The Rockefeller Foundation on COVID and co-author of the Foundation’s national reports on the pandemic. She has served on the board of directors for OraSure Technologies, Inc. since 2017. Aspinall is passionate about education and co-founded the Biomedical Diagnostics School at Arizona State University, the only program in the world dedicated to the study of diagnostics.
Featured Speaker
Frank Middleton, PhD
Professor in the Departments of Neuroscience & Physiology, Psychiatry & Behavioral Sciences, and Biochemistry & Molecular Biology at SUNY Upstate Medical University. Dr. Middleton’s research on these large-scale health issues has been published in more than 160 peer-reviewed articles and a dozen book chapters. He is the founder and director of the SUNY Molecular Analysis Core facility, which specializes in next-generation sequencing analysis and applied his expertise in RNA analysis to develop the Clarifi COVID-19 Saliva Test.
Featured Speaker
Jennifer S. Smith, PhD, MPH
Professor in the Department of Epidemiology at the University of North Carolina Gillings School of Global Public Health in Chapel Hill. Dr. Smith is also affiliated with the UNC Lineberger Comprehensive Cancer Center, UNC Center for AIDS Research and the UNC Center for Women’s Health Research. Dr. Smith has conducted research on HPV infection, associated cervical neoplasia and cancer since 1995, and has published over 300 articles in international peer-reviewed journals.
Panelists:
By submitting this request, I consent to receive follow-up emails from DNA Genotek Inc., its parent company, OraSure Technologies, Inc. and their affiliates, about products and services, news, and promotions. Please refer to our Privacy Policy or Contact Us for more details. I understand that I can withdraw consent at any time.
Join us for an educational hotel industry workshop
Register to receive the link to the workshop recording
Join us for an educational hotel industry workshop
Register to receive the link to the workshop recording